Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Abilify Mycite(Aripiprazole)Otsuka Holdings Co., Ltd. logo4578.T

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Otsuka Holdings Co., Ltd.

$90K

Medicare cost, 2024

Medicare drug plans spent $90,322 on Abilify Mycite (aripiprazole) in 2024, for 53 prescriptions and refills filled by 16 patients. Spending rose 20% from 2023 to 2024. It is made by Otsuka Holdings Co., Ltd. (4578.T).

Medicare cost, 2024

$90K

+19.8% from 2023

Prescriptions

53

$1,704.20 per claim

Patients

16

11 prescribers

Total spending, 2024

$90K

$5,645.15 per patient

Questions and answers

How much does Medicare spend on Abilify Mycite?

Medicare prescription drug plans paid $90K for Abilify Mycite in 2024, for 53 prescriptions and refills to 16 patients (up 19.8% from 2023). The average cost per claim was $1,704.20.

Which state spends the most on Abilify Mycite?

California had the highest Medicare cost for Abilify Mycite in 2024: $42K for 25 claims.

Who prescribes Abilify Mycite the most?

Douglas Sears, specialist in Encino, CA, had the highest Medicare cost for Abilify Mycite in 2024: 25 claims costing $42K.

Who makes Abilify Mycite?

Abilify Mycite is made by Otsuka Holdings Co., Ltd. (4578.T), listed in the Medicare spending data as Otsuka America.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Abilify Mycite was $90K in 2024, after a high of $92K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Abilify Mycite, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Douglas Sears Encino, CASpecialist25Under 11$42K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022744-$76K
2023844-$75K
2024115316$90K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Otsuka America4578.T logo4578.T53$90K

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube